Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...
The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human ...
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...
The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...
The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV ...
US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved ...
China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the ...
Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help ...
Merck (MRK) announced that the National Medical Products Administration of China approved Gardasil Vaccine for use in males 9-26 years of age ...
Merck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration ...
As China experiences a rise in respiratory infections this winter, one little-known virus has gotten a lot of attention – and ...
U.S. drugmaker Merck & Co has received approval in China for its HPV vaccine's use in males, expanding its market reach despite earlier weak sales in the region. This move marks a potential growth ...